Search results for

For those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.

Biden's comments — made as officials try to convince Americans to get a new booster shot and the White House seeks $22 billion in new COVID funding — were "unfortunate," several epidemiologists said.

The pandemic pushed many South Africans out of work. Some grabbed land and put up shacks. There's a community called "Covid" — and even "Sanitizer." The Anti-Land Invasion Unit aims to tear them down.

The coronavirus keeps evolving and so does the guidance for addressing it. As cases tick up in some parts of the country, here is the latest advice on everything from testing to treatment.

Three years ago, the emergency declaration enabled certain tools for fighting the pandemic and protecting Americans. Now that it's expiring, here's what is changing — and what's not.

As China lifts its stringent zero-COVID policy, public health messaging has taken a U-turn. People are grappling with the whiplash, trying to find a way to protect themselves and loved ones.

So far the government has distributed nearly 400,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away.

During the pandemic scientists launched a vaccine in record-breaking time. Their successful use of mRNA technology could lead to progress in the decades-long effort for an HIV inoculation.

As part of spending negotiations between the White House and House Republicans, pandemic-era aid is getting pulled back. A document circulated by the White House shows what would be cut.

Updated versions of the mRNA vaccines roll out this week. Experts say they offer good protection against current COVID variants. Who should get them, and when's the best time to roll up your sleeve?